Category: Blog

  • SoundHound CEO Says Company Now Outperforms Industry Giants: ‘We Beat The Big Tech … By As Much As 35%-40%’

    SoundHound CEO Says Company Now Outperforms Industry Giants: ‘We Beat The Big Tech … By As Much As 35%-40%’

    by

    in

    SoundHound AI Inc (NASDAQ:SOUN) isn’t mincing words about where it stands in the artificial intelligence race. “We beat the big tech and some of the industry giants by as much as 35%–40% in accuracy, several times in latency, and we can run it at a lower cost,” CEO Kevan Mahajer said during the company’s third-quarter…

  • Dow Dips Over 200 Points; Fluor Shares Slide After Q3 Results

    Dow Dips Over 200 Points; Fluor Shares Slide After Q3 Results

    by

    in

    U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 200 points on Friday. The Dow traded down 0.47% to 46,693.85 while the NASDAQ fell 1.42% to 22,725.49. The S&P 500 also fell, dropping, 0.82% to 6,664.90. Check This Out: Jim Cramer: Chipotle Is ‘Too Expensive,’ Buy This Plane Makerv…

  • Flying-Taxi Maker Archer Loses Altitude As Investors Question Costly Airport Move

    Flying-Taxi Maker Archer Loses Altitude As Investors Question Costly Airport Move

    by

    in

    Archer Aviation Inc. (NYSE:ACHR) stock tumbled Friday after the company reported third-quarter results and plans to acquire Hawthorne Airport. Earnings Snapshot On Thursday, Archer reported third-quarter financial results, posting a loss of 20 cents per share, which was narrower than the 31-cent loss analysts had estimated. The company reported a third-quarter adjusted EBITDA loss of…

  • FDA Clears Johnson & Johnson’s Darzalex Faspro, Enabling Early Intervention In Myeloma Progression

    FDA Clears Johnson & Johnson’s Darzalex Faspro, Enabling Early Intervention In Myeloma Progression

    by

    in

    The U.S. Food and Drug Administration (FDA) approved on Thursday Johnson & Johnson’s (NYSE:JNJ) Darzalex Faspro (daratumumab and hyaluronidase-fihj) for a type of blood cancer. Darzalex Faspro is the first and only approved treatment for high-risk smoldering multiple myeloma (HR-SMM), enabling earlier intervention before the disease progresses to active multiple myeloma. Smoldering multiple myeloma is…

  • A Look at Organon’s Upcoming Earnings Report

    by

    in

    Organon (NYSE:OGN) is gearing up to announce its quarterly earnings on Monday, 2025-11-10. Here’s a quick overview of what investors should know before the release. Analysts are estimating that Organon will report an earnings per share (EPS) of $0.92. The announcement from Organon is eagerly anticipated, with investors seeking news of surpassing estimates and favorable…

  • A Glimpse of uniQure’s Earnings Potential

    by

    in

    uniQure (NASDAQ:QURE) will release its quarterly earnings report on Monday, 2025-11-10. Here’s a brief overview for investors ahead of the announcement. Analysts anticipate uniQure to report an earnings per share (EPS) of $-0.79. Investors in uniQure are eagerly awaiting the company’s announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.…

  • A Look at Microvast Holdings’s Upcoming Earnings Report

    A Look at Microvast Holdings’s Upcoming Earnings Report

    by

    in

    Microvast Holdings (NASDAQ:MVST) is gearing up to announce its quarterly earnings on Monday, 2025-11-10. Here’s a quick overview of what investors should know before the release. Analysts are estimating that Microvast Holdings will report an earnings per share (EPS) of $0.05. The market awaits Microvast Holdings’s announcement, with hopes high for news of surpassing estimates…

  • Exploring Stellus Cap Investment’s Earnings Expectations

    by

    in

    Stellus Cap Investment (NYSE:SCM) is gearing up to announce its quarterly earnings on Monday, 2025-11-10. Here’s a quick overview of what investors should know before the release. Analysts are estimating that Stellus Cap Investment will report an earnings per share (EPS) of $0.31. Stellus Cap Investment bulls will hope to hear the company announce they’ve…

  • EVgo Earnings Preview

    by

    in

    EVgo (NASDAQ:EVGO) is gearing up to announce its quarterly earnings on Monday, 2025-11-10. Here’s a quick overview of what investors should know before the release. Analysts are estimating that EVgo will report an earnings per share (EPS) of $-0.17. The announcement from EVgo is eagerly anticipated, with investors seeking news of surpassing estimates and favorable…

  • Examining the Future: DoubleDown Interactive’s Earnings Outlook

    by

    in

    DoubleDown Interactive (NASDAQ:DDI) is preparing to release its quarterly earnings on Monday, 2025-11-10. Here’s a brief overview of what investors should keep in mind before the announcement. Analysts expect DoubleDown Interactive to report an earnings per share (EPS) of $0.60. The announcement from DoubleDown Interactive is eagerly anticipated, with investors seeking news of surpassing estimates…